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Previous studies have shown that oesophageal and gastric cancers are the most common causes of cancer death in the Golestan 
Province, Iran. In 2001, we established Atrak Clinic, a referral clinic for gastrointestinal (GI) diseases in Gonbad, the major city of 
eastern Golestan, which has permitted, for the first time in this region, endoscopic localisation and histologic examination of upper GI 
cancers. Among the initial 682 patients seen at Atrak Clinic, 370 were confirmed histologically to have cancer, including 223 (60%) 
oesophageal squamous cell cancers (ESCC), 22 (6%) oesophageal adenocarcinomas (EAC), 58 (16%) gastric cardia adenocarcinomas 
(GCA), and 58 (16%) gastric noncardia adenocarcinomas. The proportional occurrence of these four main site-cell type subdivisions 
of upper GI cancers in Golestan is similar to that seen in Linxian, China, another area of high ESCC incidence, and is markedly 
different from the current proportions in many Western countries. Questioning of patients about exposure to some known and 
suspected risk factors for squamous cell oesophageal cancer confirmed a negligible history of consumption of alcohol, little use of 
cigarettes or nass (tobacco, lime and ash), and a low intake of opium, suggesting that the high rates of ESCC seen in northeastern Iran 
must have other important risk factors that remain speculative or unknown. Further studies are needed to define more precisely the 
patterns of upper GI cancer incidence, to test other previously suspected risk factors, and to find new significant risk factors in this 
high-risk area. 
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A cancer registry maintained by the International Agency for 
Research on Cancer (IARC) and the Institute of Public Health 
Research of Tehran University (IPHR) showed that from June 1968 
to June 1971 the age-adjusted incidence rates of oesophageal 
cancer (EC) for both men and women from Golestan Province who 
lived in the steppe grasslands of the Turkmen plain and 
neighbouring hills in the north-eastern part of the province were 
higher than 100/100 000 and thus among the highest rates in the 
world (Kmet and Mahboubi, 1972; Mahboubi et al, 1973). 
Moreover, whereas in Western countries EC has been mainly a 
disease of men who smoke and drink alcohol heavily (Munoz and 
Day, 1996; Brown et al, 2001), in the very high incidence areas of 
Golestan Province (inhabited almost entirely by Turkmens) there 
were very low rates of smoking and drinking and EC was slightly 
more common in women than in men. The cancer registry also 
showed sharp gradients of incidence over relatively short 
geographical distances. Rates fell westward for some 300 km along 
the southern Caspian littoral (a densely populated area inhabited 
largely by Persians) through Mazandaran Province and into Gilan 
Province (a much wetter region of rice paddies and orange groves) 
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where the incidence was lower than 10 per 100 000 in women and 
between 10 and 20 per 100 000 for men. 
Ecological and nutritional studies conducted by IARC and IPHR 
to establish the epidemiologic features and to investigate the 
aetiology of EC throughout the Caspian Littoral including Golestan 
Province (Joint Iran-IARC Cancer Study Group, 1977) found 
geographical associations of incidence with a number of variables. 
A subsequent case – control study investigated these associations 
further and established some risk factors, especially poverty and a 
restricted diet very low in fresh fruit and vegetables (Cook-
Mozaffari et al, 1979), factors that have since been shown to be 
associated with an elevated risk for oesophageal cancer in almost 
all countries where diet has been studied (Munoz and Day, 1996), 
but it found no clear evidence for other potential risk factors such 
as hot tea or nass consumption. However, the studies in Iran were 
discontinued due to the sociopolitical changes there in 1979, 
before the complete patterns of incidence and the full complement 
of risk factor results could be established. Some of the major 
questions that were left unanswered were the precise incidence of 
EC and GC and the proportions of different histologic subtypes of 
oesophageal tumours in the different ethnicities in Golestan 
Province, partly because population data by ethnic group were 
not available and partly because the lack of endoscopy and 
histological diagnoses may have led to incorrect designation of 
tumour location and histology for a proportion of patients. It was 
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postulated at the time that almost all the oesophageal cancer cases 
in this area were of squamous origin, but 98% of the tumours were 
diagnosed by radiology or by clinical methods alone and only 2% 
had histological confirmation (Mahboubi et al, 1973). 
In August 2001, we opened a referral clinic for upper 
gastrointestinal (GI) tract cancers, the Atrak Clinic, in the principal 
city of the region, Gonbad, at the Khatam hospital, the largest 
hospital of eastern Golestan. The Clinic is affiliated with and 
staffed by the Digestive Disease Research Centre (DDRC) of 
Tehran University of Medical Sciences. Our aims were both to 
provide care for patients and to build on the previously unfinished 
research studies. Here, we report on the patients seen in the first 24 
months of Atrak Clinic, including the location and histology of the 
oesophageal and gastric cancers and some epidemiological features 
of these cancer cases. We also compare our findings with those of 
the previous studies in Iran and with the epidemiological features 
of GI cancers seen in Linxian, China, another area with extremely 
high rates of EC. 
MATERIALS AND METHODS 
The majority of cancer patients in eastern Golestan present first to 
the local general practitioners or to the medical and surgical 
specialists in the area, and only a small group of patients are first 
diagnosed in major cities outside the area. Before the study began, 
the investigators contacted all of the local medical practitioners 
and asked them to refer their patients with suspected GI tract 
cancers to the Atrak Clinic. From August 2001 to August 2003, 682 
patients were referred to the Atrak Clinic. Based on the results of a 
recent cancer surveillance study and an ongoing cancer registra­
tion in Golestan Province, we have shown that approximately 70% 
of the incident cases of oesophageal cancer recorded in the eastern 
part of Golestan Province during the study period were referred to 
the Clinic (unpublished data), so the results of this report may be 
generalised to represent the experience of eastern Golestan 
Province. 
All the 682 patients referred to the Atrak Clinic were suspected 
of having upper GI cancers. After signing an informed consent, the 
patients were interviewed by a physician using a structured 
questionnaire and underwent physical examination followed by 
oesophago-gastro-duodenal videoendoscopy. Intravenous Mida­
zolam (5 mg) and 10% lidocaine spray to the pharynx were used as 
premedication. Local medical specialists, who had been given 
specific training, performed the endoscopies using Olympus GIF­
XQ230 and Pentax EG-2900 video endoscopes. At least four 
biopsies were obtained from all of the tumours that were found 
during endoscopy and standard biopsies were taken from the 
antrum, the gastric body (lesser curvature), the cardia and the 
oesophagus in all patients. Two more biopsies were taken from 
columnar-lined distal oesophagus, if such tissue existed. The 
endoscopic data were entered on predesigned forms, and the 
location of the tumours was either captured and registered 
electronically (90% of the tumours), or precisely drawn on a 
specially designed form. An experienced endoscopist (R Malekza­
deh) reviewed both the endoscopic reports and the captured 
images to confirm the exact site of the tumours. Biopsy specimens 
were oriented and spread on strips of filter paper and fixed 
immediately in 10% buffered formalin. The samples were sent to 
the DDRC, in Tehran, where they were embedded, sectioned and 
stained with haematoxylin and eosin and examined by experienced 
DDRC pathologists (M Sotoudeh and B Abedi). 
The cancers were classified into four groups: oesophageal 
squamous cell carcinoma (ESCC), oesophageal adenocarcinoma 
(EAC), gastric cardia adenocarcinoma (GCA) and gastric non­
cardia adenocarcinoma (GNCA). Adenocarcinomas of the stomach 
were classified as intestinal or diffuse type using Lauren’s 
classification criteria (Lauren, 1965). Gastric cardia tumours were 
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defined as adenocarcinoma with an estimated point of origin 
within 1 cm proximal or 3 cm distal of the oesophago-gastric 
junction. 
The study was reviewed and approved by the Institutional 
Review Boards of the DDRC and the US National Cancer Institute. 
RESULTS 
Among the initial 682 patients, 398 were suspected at endoscopy of 
having upper GI tract cancer and 370 subsequently had histological 
confirmation of malignancy. Table 1 summarises the sites and the 
histological diagnoses found in these 370 patients. ESCC was the 
most common type of cancer seen at the Atrak Clinic, constituting 
91% of all oesophageal cancers and 60% of all upper GI cancers. 
The middle third of the oesophagus was the most frequent site of 
origin of these tumours: 32 (13%) of all oesophageal tumours were 
found in the upper third, 135 (54%) in the middle third, and 82 
(33%) in the lower third. EAC was relatively uncommon, 
comprising only 9% of all oesophageal cancers and 6% of all 
upper GI cancers. The gastric cancers were evenly split between 
GCA and GNCA. Among patients diagnosed with gastric 
adenocarcinoma, the intestinal type of cancer was approximately 
twice as frequent as the diffuse type. 
Table 2 summarises the demographic characteristics of the 361 
cancer patients diagnosed with ESCC, EAC, GCA or GNCA, and of 
the 284 patients with no endoscopically suspicious lesion 
(noncancer patients). Median age was close to 65 years in cancer 
patients and 60 in the noncancer patients. The male to female ratio 
was close to 1 : 1 in ESCC, EAC patients and noncancer patients 
and close to 3 : 1 in GCA and GNCA patients. In all, 31% of the 
ESCC, EAC, and GCA patients, 40% of the GNCA patients and 45% 
of the noncancer patients were from urban areas. There were no 
significant differences in the proportion of urban residence among 
the first three cancer groups. A higher proportion of ESCC, EAC 
and GCA, but not GNCA patients, were from rural areas compared 
with the noncancer patients (w 2 12.9, Po0.001 and 0.65, P ¼ 0.42, 
respectively). Totally, 54% of ESCC, EAC and GCA patients, but 
only 36% of GNCA and 32% of noncancer patients were Turkmens; 
the proportions of Turkmens were significantly higher for both 
Table 1 Site and histological diagnosis of the upper gastrointestinal 
cancers in patients referred to the Atrak Clinic 
Histological type Frequency 
Oesophageal squamous cell carcinoma 223 (60%) 
Oesophageal adenocarcinoma 22 (6%) 
Intestinal type 11 
Diffuse type 8 
Not determined 3 
Gastric cardia adenocarcinoma 58 (16%) 
Intestinal type 35 
Diffuse type 16 
Not determined 7 
Gastric noncardia adenocarcinoma 58 (16%) 
Intestinal type 34 
Diffuse type 17 
Not determined 7 
Others 9 (2%) 
Oesophageal adenosquamous carcinoma 4 
Gastric lymphoma 1 
Duodenal adenocarcinoma 4 
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Table 2 Demographic characteristics of cancer and noncancer patients referred to the Atrak Clinic 
Oesophageal cancer Gastric cancer Patients with no 
endoscopically 
Squamous cell Adenocarcinoma suspicious lesion 
Characteristic carcinoma (n ¼ 223) (n ¼ 22) Cardia (n ¼ 58) Noncardia (n ¼ 58) (n ¼ 284) 
Median age (interquartile 65 (55 –72) 66 (58– 74) 66 (57– 73) 64 (59 –72) 60 (47–69) 
range) 
Sex (male) 116 (52%) 13 (59%) 42 (72%) 44 (76%) 154 (54%) 
Residence (urban) 70 (31%) 7 (32%) 17 (29%) 23 (40%) 129 (45%) 
Ethnicity (Turkmen) 119 (53%) 14 (64%) 31 (53%) 21 (36%) 92 (32%) 
Table 3 Prevalence of some suggested oesophageal cancer risk factors in patients referred to the Atrak Clinic 
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Oesophageal cancer Gastric cancer Patients with no 
endoscopically 
Squamous cell Adenocarcinoma suspicious lesion 
carcinoma (n ¼ 144) (n ¼ 12) Cardia (n ¼ 42) Noncardia (n ¼ 40) (n ¼ 260) 
Characteristic 
Alcohol (ever consumed) 1 (1%) 1 (10%) 0 (0%) 0 (0%) 5 (2%) 
Smoking (ever smoked) 39 (27%) 3 (25%) 14 (33%) 12 (30%) 51 (20%) 
Nass (ever used) 18 (12%) 3 (25%) 6 (14%) 6 (15%) 23 (9%) 
Opiuma 
New users 9 (6%) 0 (0%) 4 (10%) 6 (15%) 15 (6%) 
Old users 39 (27%) 4 (33%) 11 (26%) 14 (35%) 56 (22%) 
Any risk factorb 69 (48%) 5 (42%) 23 (55%) 22 (55%) 102 (39%) 
aNew user refers to those who started opium use during the year before the diagnosis was made. Old user refers to those started opium use earlier than 1 year before the 
diagnosis. bAny risk factor refers to using at least one of the four risk factors (alcohol, cigarette, nass or opium). 
oesophageal and GCA patients, but not for GNCA patients, than 
for noncancer patients (w 2 28.2 Po0.001 and 0.32 P ¼ 0.57). There 
were no significant differences in Turkmen ethnicity among the 
ESCC, EAC and GCA groups (w 2 0.86 and P ¼ 0.66). 
Table 3 shows the prevalence of previous exposure to some 
known or suspected risk factors for ESCC, including alcohol 
consumption, cigarette smoking, the chewing of nass and opium 
consumption. These data were available for only 238 cancer 
patients and 260 noncancer patients. Only two (1%) of the cancer 
patients and five (2%) of the noncancer patients had ever 
consumed alcohol. In total, 29% of all cancer patients and 20% 
of noncancer patients had ever smoked. Smoking was more 
frequent among men: 39% of all male cancer patients and 12% of 
all female cancer patients had ever smoked, with rates being very 
similar across the cancer groups. Nass was used by 14% of cancer 
patients and 9% of noncancer patients, and opium consumption 
was seen in 37% of all cancer patients and 29% of noncancer 
patients. To investigate whether opium consumption was an old 
habit or it was used as a medication to alleviate pain from a recent 
disease, we asked the patients about the time they had started 
using opium. Those who had started in the year prior to being 
referred to Atrak Clinic were classified as new users. In all, 27% of 
ESCC patients had started their opium use earlier than 1 year ago, 
and 6% had started in the year before being referred to the Atrak 
Clinic. Taken together, 50% of all cancer patients and 39% of 
noncancer patients had ever used at least one of these risk factors. 
DISCUSSION 
In total, 245 cases of oesophageal cancer and 116 cases of gastric 
cancer were referred to the Atrak Clinic in the first 24 months after 
it was opened. Assuming that the proportion of UGI cancer cases 
referred to the clinic was independent of tumour site, we can 
conclude that EC is approximately twice as common as GC in 
eastern Golestan Province. In addition, almost half of the GC cases 
occurred in the cardia of the stomach. A predominance of EC cases 
over GC cases and a large number of GC cases originating in the 
cardia are common findings in populations at high risk for EC, but 
are unusual findings for other areas of the world. For example in 
Linxian, China, another area with very high rates of EC, the EC : GC 
ratio is also greater than one and the GCA cases far outnumber the 
cases of GNCA (Blot et al, 1993), but in most areas of the world, the 
opposite proportions are found. 
Compared to the cancer registry rates for 1969 –1971 in this 
area, which showed an EC : GC ratio of 8 : 1 (Mahboubi et al, 1973), 
the current much lower 2 : 1 ratio might seem to imply that 
changes in incidence have occurred for either or both sites in 
eastern Golestan, but a substantial part of the difference may be an 
artefact of diagnostic method and classification. ESCC, EAC and 
GCA all usually present with dysphagia as the dominant symptom, 
while GNCA usually presents with abdominal pain without 
dysphagia. In the 1970s, when endoscopy was not available in 
the region, ESCC, EAC and GCA were probably all diagnosed as 
EC, while only GNCA was diagnosed as GC. Also supporting this 
possibility is the observation that in the 1970s more than half of 
the oesophageal cancers were located in the lower third (Mahboubi 
et al, 1973), while in the present series only a third of these 
tumours were localised to that site. This difference could be 
explained by some of the cancers previously classified as lower 
third oesophageal tumours now being more accurately classified as 
GCA. If one combines the current figures for ESCC, EAC and GCA, 
the EC : GC ratio is 5 : 1. Of course, some real changes in the 
incidence of these tumours may also have occurred and some of 
the changes may be due to differential levels of referral, but much 
of the apparent change in their proportions appears to be due to 
these changes in diagnostic method and classification. 
ESCC is the dominant histological type of EC in eastern Golestan 
Province, since more than 90% of the EC cases in this series were 
ESCC. This predominance of ESCC : EAC is also seen in other high-
risk EC populations, but is not as common in populations with low 
EC risk. In Linxian, for example, virtually all EC cases are ESCC, 
but in the US, the proportion of EAC cases among all oesophageal 
cancer cases has increased from 14 to 51% from 1975 to 1998, and 
intestinal type EAC is now the predominant histological type 
(Polednak, 2003). Similar sharp increases in incidence of EAC have 
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also been reported from Europe (Walther et al, 2001; Powell et al, 
2002), but no such trend has been observed in Golestan Province. 
In this series, intestinal-type tumours were the predominant type 
of adenocarcinomas, being twice as frequent as the diffuse-type 
tumours. This pattern and strong male predominance for gastric 
carcinomas in Golestan are similar to the patterns observed in 
other high-incidence rate areas of the world (Nomura, 1996). 
ESCC was equally distributed between the two sexes, similar to 
the ratio in Linxian, but completely different from the pattern seen 
in Western countries, where the incidence of ESCC is low but is 
several-fold higher in men than in women (Munoz and Day, 1996). 
The proportion of ESCC, EAC and GCA cases who were from 
rural areas or were of Turkmen ethnicity were similar and were 
higher than the proportions of these characteristics among GNCA 
or noncancer patients. Finding characteristics in which GCA 
patients are more similar to oesophageal cancer patients than to 
GNCA patients is also common in Linxian (Blot et al, 1993; Mark 
et al, 2000; Taylor et al, 2003). 
Only one of the 144 ESCC cases had ever consumed alcohol, so 
alcohol cannot be considered a risk factor for ESCC in Golestan 
Province. It also appears that smoking is not a predominant risk 
factor. Only 27% of ESCC patients had ever smoked, and this 
proportion was similar to the proportion of smokers in the other 
cancer groups and noncancer patients. In addition, despite higher 
rates of smoking among men in Golestan (10.4% in men vs 0.4% in 
women in a large survey of the general population in this area 
(Noorbala and Mohammad, 1999)), ESCC incidence rates in this 
region are similar in men and women. A similar situation has been 
reported in Linxian, where smoking is much more common in 
men, the ESCC rates are similar in men and women, and the 
relative risk of ESCC associated with smoking is 1.6 (Guo et al, 
1994; Abnet et al, 2001), making only 15% of the ESCC cases 
attributable to smoking. A totally different pattern is seen in 
Western countries: approximately 92% of all ESCC cases in the US 
have been attributed to smoking and alcohol consumption (Brown 
et al, 2001). However, it should be noted that most of the cases in 
most Western studies are men, and a recent study confined to 
women in the UK showed no association with alcohol and only a 
slight elevation of risk associated with smoking (Sharp et al, 2001). 
Nass chewing, another locally suspected risk factor for ESCC, 
was seen in 12% of ESCC cases (18% of male and 6% of female 
patients), similar to the rates in the other cancer groups and in 
noncancer patients. The findings for the chewing of nass are in 
keeping with the results of the earlier case –control study which 
showed no elevation of risk for nass consumption (Cook-Mozaffari 
et al, 1979). 
The consumption of opium, and in particular of opium dross 
(shireh and sukhteh), has been suspected to be a major aetiological 
factor for ESCC in Golestan Province (Joint Iran-IARC Study 
Group, 1977; Hewer et al, 1978; Malaveille et al, 1982; Dowlatshahi 
and Miller, 1985; Ghadirian et al, 1985). One-third (33%) of ESCC 
patients in our study had ever used opium, and similar 
proportions of opium usage were seen in the other patients. In 
order to evaluate the validity of such questionnaire responses 
concerning opium use among our patients, we recently measured 
opium metabolites in urines of 150 Golestan adults who responded 
to a similar questionnaire, evenly divided between those who 
admitted using opium and those who did not. Opium consumption 
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since been associated with elevated risk in other parts of the world 
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The studies that were conducted in the 1970s in the Caspian 
Littoral and Golestan Province showed that areas inhabited by 
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mainly Persian population, although the differences were less 
marked within Golestan Province (Kmet and Mahboubi, 1972; 
Mahboubi et al, 1973). In our study, approximately 50% of ESCC 
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indicated by the interim results of the cancer registry) and if all the 
patients who have not been referred to our clinic were Turkmens, 
the risk of ESCC in Turkmens would be 1.99 that of the risk in 
non-Turkmens. This analysis argues against the existence of strong 
Turkmen-specific genetic components in the aetiology of ESCC in 
eastern Golestan. Only two (1%) of the ESCC cases were younger 
than 30 years of age and eight (4%) were younger than 40 years of 
age, another finding that argues against genetic factors being the 
predominant aetiological factors. 
In summary, the results of this study show that ESCC is still the 
predominant type of upper GI cancer in high-risk areas of 
Golestan Province, and that tobacco, nass, alcohol and perhaps 
opium consumption are not the major aetiological factors for 
ESCC in this area. ESCC seems to be distributed among both 
Turkmens and non-Turkmens, and among both city and village 
dwellers. Therefore, it is likely that the main aetiologic factors for 
high incidence of ESCC are factors that are shared by most 
inhabitants of this area. Further case –control and cohort studies 
are needed to explore the risk factors associated in this region with 
the very high rates of ESCC. 
ACKNOWLEDGEMENTS 
This study was supported by a grant from DDRC. We would like to 
thank the Iranian Social Security Organization for their strong 
local support. 
Reliability and validity of opiate use self-report in a population at high 
risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol 
Biomarkers Prev (in press) 
Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, 
Gail M, Li GY (1993) Nutrition intervention trials in Linxian, China: 
E
p
id
e
m
io
lo
g
y
 
& 2004 Cancer Research UK British Journal of Cancer (2004) 90(7), 1402 – 1406 
Upper GI cancer in Iran 
F Islami et al 
1406 
E
p
id
e
m
io
lo
g
y
 
supplementation with specific vitamin/mineral combinations, cancer 
incidence, and disease-specific mortality in the general population. J Natl 
Cancer Inst 85: 1483 – 1492 
Brown LM, Hoover R, Silverman D, Baris D, Hayes R, Swanson GM, 
Schoenberg J, Greenberg R, Liff J, Schwartz A, Dosemeci M, Pottern L, 
Fraumeni Jr JF (2001) Excess incidence of squamous cell esophageal 
cancer among US Black men: role of social class and other risk factors. 
Am J Epidemiol 153: 114 – 122 
Cook-Mozaffari PJ, Azordegan F, Day NE, Ressicaud A, Sabai C, Aramesh B 
(1979) Oesophageal cancer studies in the Caspian Littoral of Iran: results 
of a case – control study. Br J Cancer 39: 293 – 309 
Dowlatshahi K, Miller RJ (1985) Role of opium in esophageal cancer: a 
hypothesis. Cancer Res 45: 1906 – 1907 
Ghadirian P (1987) Thermal irritation and esophageal cancer in northern 
Iran. Cancer 60: 1909 – 1914 
Ghadirian P, Stein GF, Gorodetzky C, Roberfroid MB, Mahon GA, Bartsch 
H, Day NE (1985) Oesophageal cancer studies in the Caspian littoral of 
Iran: some residual results, including opium use as a risk factor. Int J 
Cancer 35: 593 – 597 
Guo W, Blot WJ, Li JY, Taylor PR, Liu BQ, Wang W, Wu YP, Zheng W, 
Dawsey SM, Li B (1994) A nested case – control study of oesophageal and 
stomach cancers in the Linxian nutrition intervention trial. Int J 
Epidemiol 23: 444 – 450 
Hewer T, Rose E, Ghadirian P, Castegnaro M, Malaveille C, Bartsch H, Day 
N (1978) Ingested mutagens from opium and tobacco pyrolysis products 
and cancer of the oesophagus. Lancet 2: 494 – 496 
Joint Iran-International Agency for Research on Cancer Study Group 
(1977) Esophageal cancer studies in the Caspian littoral of Iran: results of 
population studies – a prodrome. J Natl Cancer Inst 59: 1127 – 1138 
Kmet J, Mahboubi E (1972) Esophageal cancer in the Caspian littoral of 
Iran: initial studies. Science 175: 846 – 853 
Lauren P (1965) The two histological main types of gastric carcinoma. 
Diffuse and so-called intestinal-type. Acta Pathol Microbiol 64: 31 – 49 
Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S (1973) 
Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian 
cancer registry. Br J Cancer 28: 197 – 214 
Malaveille C, Friesen M, Camus AM, Garren L, Hautefeuille A, 
Bereziat JC, Ghadirian P, Day NE, Bartsch H (1982) Mutagens 
produced by the pyrolysis of opium and its alkaloids as possible 
risk factors in cancer of the bladder and oesophagus. Carcinogenesis 3: 
577 – 585 
Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, Fraumeni Jr 
JF, Blot WJ, Dong ZW, Taylor PR (2000) Prospective study of serum 
selenium levels and incident esophageal and gastric cancers. J Natl 
Cancer Inst 92: 1753 – 1763 
Munoz N, Day NE (1996) Esophageal cancer. In Cancer Epidemiology and 
Prevention, Schottenfeld D, Fraumeni JF (eds) pp 681 – 706. New York: 
Oxford University Press 
Nomura A (1996) Stomach cancer. In Cancer Epidemiology and Prevention, 
Schottenfeld D, Fraumeni JF (eds) pp 707 – 724. New York: Oxford 
University Press 
Noorbala A, Mohammad K (1999) National Health Survey in Iran. Tehran, 
Iran, Iranian Ministry of Health, Undersecretary for Research (Mono­
graph) 
Polednak AP (2003) Trends in survival for both histologic types of 
esophageal cancer in US surveillance, epidemiology and end results 
areas. Int J Cancer 105: 98 – 100 
Powell J, McConkey CC, Gillison EW, Spychal RT (2002) Continuing 
rising trend in oesophageal adenocarcinoma. Int J Cancer 102: 
422 – 427 
Sharp L, Chilvers CE, Cheng KK, McKinney PA, Logan RF, CookMozaffari 
P, Ahmed A, Day NE (2001) Risk factors for squamous cell carcinoma 
of the oesophagus in women: a case – control study. Br J Cancer 85: 
1667 – 1670 
Taylor PR, Qiao YL, Abnet CC, Dawsey SM, Yang CS, Gunter EW, Wang W, 
Blot WJ, Dong ZW, Mark SD (2003) Prospective study of serum 
vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst 
95: 1414 – 1416 
Walther C, Zilling T, Perfekt R, Moller T (2001) Increasing prevalence of 
adenocarcinoma of the oesophagus and gastro-oesophageal junction: a 
study of the Swedish population between 1970 and 1997. Eur J Surg 167: 
748 – 757 
British Journal of Cancer (2004) 90(7), 1402 – 1406 & 2004 Cancer Research UK 
